Wuhan Keqian Biology Co.,Ltd reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 827.44 million compared to CNY 686.52 million a year ago. Revenue was CNY 827.44 million compared to CNY 686.52 million a year ago.

Net income was CNY 357.43 million compared to CNY 283.43 million a year ago. Basic earnings per share from continuing operations was CNY 0.77 compared to CNY 0.61 a year ago. Diluted earnings per share from continuing operations was CNY 0.77 compared to CNY 0.61 a year ago.